Home Cart Sign in  
Chemical Structure| 1408064-71-0 Chemical Structure| 1408064-71-0

Structure of JNK-IN-7
CAS No.: 1408064-71-0

Chemical Structure| 1408064-71-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

JNK-IN-7 is a potent inhibitor for JNK all isoforms with IC50 values of 1.5, 2 and 0.7 nM for JNK1, JNK2 and JNK3, respectively.

Synonyms: JNK inhibitor; JNK Inhibitor VII; c-Jun N-terminal Kinase Inhibitor VII

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of JNK-IN-7

CAS No. :1408064-71-0
Formula : C28H27N7O2
M.W : 493.56
SMILES Code : O=C(NC1=CC=C(NC2=NC=CC(C3=CC=CN=C3)=N2)C=C1)C4=CC=CC(NC(/C=C/CN(C)C)=O)=C4
Synonyms :
JNK inhibitor; JNK Inhibitor VII; c-Jun N-terminal Kinase Inhibitor VII
MDL No. :MFCD25976765
InChI Key :RADRIIWGHYFWPP-WEVVVXLNSA-N
Pubchem ID :57340685

Safety of JNK-IN-7

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of JNK-IN-7

MAPK
TLR

Isoform Comparison

Biological Activity

Target
  • JNK1

    JNK1, IC50:1.5 nM

  • JNK2

    JNK2, IC50:2 nM

  • JNK3

    JNK3, IC50:0.7 nM

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.03mL

0.41mL

0.20mL

10.13mL

2.03mL

1.01mL

20.26mL

4.05mL

2.03mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories